Higher prevalence but later age at onset of asthma in cross-country skiers compared with general population.
Adolescent
Adrenal Cortex Hormones
/ therapeutic use
Adrenergic beta-2 Receptor Agonists
/ therapeutic use
Age of Onset
Asthma
/ drug therapy
Bronchodilator Agents
/ therapeutic use
Cold Temperature
Competitive Behavior
Cross-Sectional Studies
Drug Therapy, Combination
Female
Finland
/ epidemiology
Humans
Male
Physical Conditioning, Human
/ physiology
Prevalence
Skiing
/ physiology
Young Adult
asthma
asthma control
cross-country skiing
onset age of asthma
respiratory health
Journal
Scandinavian journal of medicine & science in sports
ISSN: 1600-0838
Titre abrégé: Scand J Med Sci Sports
Pays: Denmark
ID NLM: 9111504
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
revised:
03
08
2021
received:
01
07
2021
accepted:
25
08
2021
pubmed:
28
8
2021
medline:
20
11
2021
entrez:
27
8
2021
Statut:
ppublish
Résumé
Cross-country skiing causes strain in the airways because skiers train and compete in cold air. The aim of this survey was to investigate the prevalence and age at onset of asthma, asthma control, and use of asthma medication in Finnish competitive cross-country skiers. All cross-country skiers who were enrolled in the largest national competitions in winter 2019 (n = 1282) were invited to the study via the Finnish Ski Association. A control group (n = 1733) was matched for the responding skiers by age, gender, and region. The response rate was 27.4% (n = 351) for skiers and 19.5% (n = 338) for the controls. The prevalence of asthma was 25.9% in skiers and 9.2% in the controls (p < 0.001). Median (IQR) age at first asthma-related symptoms was higher in skiers than in the controls (13.0 (8.25-16.0) vs. 8.0 (2.25-11.75) years, p < 0.001), and the difference in asthma prevalence was evident only after the start of skiing career. Median (IQR) Asthma Control Test (ACT) score in skiers and controls with asthma was 22.0 (21-24) vs. 22.0 (19-24) (p = 0.611), and 89.0% of skiers and 77.4% of controls had well-controlled asthma (ACT score ≥20). In skiers with asthma, 82.4% used regular inhaled corticosteroids (ICS), and 80.2% used bronchodilators. A fixed combination of ICS +long-acting β2-agonist was regularly used by 47.3% of the skiers and 22.6% of the controls with asthma (p = 0.016). In conclusion, asthma prevalence is about 2.5 times higher, and age at onset of asthma is later in skiers compared with the controls. Asthma in cross-country skiers is mostly well controlled and on regular maintenance treatment.
Substances chimiques
Adrenal Cortex Hormones
0
Adrenergic beta-2 Receptor Agonists
0
Bronchodilator Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2259-2266Subventions
Organisme : Tampereen Tuberkuloosisäätiö
Organisme : Suomen Tuberkuloosin Vastustamisyhdistyksen Säätiö
Organisme : Väinö ja Laina Kiven Säätiö
Organisme : Urheiluopistosäätiö
Informations de copyright
© 2021 The Authors. Scandinavian Journal of Medicine & Science In Sports published by John Wiley & Sons Ltd.
Références
Global Strategy for Asthma Management and Prevention. Vol 2020. Accessed February 21, 2021. https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf
Mäki-Heikkilä R, Karjalainen J, Parkkari J, Valtonen M, Lehtimäki L. Asthma in competitive cross-country skiers: a systematic review and meta-analysis. Sports Med. 2020;50(11):1963-1981. doi:10.1007/s40279-020-01334-4.
Eklund LM, Irewall T, Lindberg A, Stenfors N. Prevalence, age at onset, and risk factors of self-reported asthma among Swedish adolescent elite cross-country skiers. Scand J Med Sci Sports. 2018;28(1):180-186. doi:10.1111/sms.12879.
Norqvist J, Eriksson L, Soderstrom L, Lindberg A, Stenfors N. Self-reported physician-diagnosed asthma among Swedish adolescent, adult and former elite endurance athletes. J Asthma. 2015;52(10):1046-1053. doi:10.3109/02770903.2015.1038389.
Lennelöv E, Irewall T, Naumburg E, Lindberg A, Stenfors N. The prevalence of asthma and respiratory symptoms among cross-country skiers in early adolescence. Can Respir J. 2019;2019:1-5. doi:10.1155/2019/1514353.
Persson H, Lindberg A, Stenfors N. Asthma control and asthma medication use among Swedish elite endurance athletes. Can Respir J. 2018;2018:4646852. doi:10.1155/2018/4646852.
Pallasaho P, Lundbäck B, Läspä SL, et al. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki study. Respir Med. 1999;93(11):798-809. doi:10.1016/S0954-6111(99)90265-2.
Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test - a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59-65. doi:10.1016/j.jaci.2003.09.008.
8th Cross-Country List 2018/2019. https://www.fis-ski.com/DB/general/fis-points-details.html?sectorcode=CC&seasoncode=2019&listid=300145
Honkamäki J, Hisinger-Mölkänen H, Ilmarinen P, et al. Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood. Respir Med. 2019;154:56-62. doi:10.1016/j.rmed.2019.06.003.
Anderson SD, Kippelen P. Exercise-induced bronchoconstriction: pathogenesis. Curr Allergy Asthma Rep. 2005;5(2):116-122. doi:10.1007/s11882-005-0084-y.
Fitch KD. beta2-agonists at the Olympic games. Clin Rev Allergy Immunol. 2006;31(2-3):259-268. doi:10.1385/CRIAI:31:2:259.
Dickinson J, McConnell A, Whyte G. Diagnosis of exercise-induced bronchoconstriction: eucapnic voluntary hyperpnoea challenges identify previously undiagnosed elite athletes with exercise-induced bronchoconstriction. Br J Sports Med. 2011;45(14):1126-1131. doi:10.1136/bjsm.2010.072520.
Larsson K, Ohlsen P, Larsson L, Malmberg P, Rydstrom PO, Ulriksen H. High prevalence of asthma in cross country skiers. BMJ (Clinical research ed). 1993;307(6915):1326-1329.
Ogston J, Butcher JD. A sport-specific protocol for diagnosing exercise-induced asthma in cross-country skiers. Clin J Sport Med. 2002;12(5):291-295.
Pohjantähti H, Laitinen J, Parkkari J, et al. Exercise-induced bronchospasm among healthy elite cross country skiers and non-athletic students. Scand J Med Sci Sports. 2005;15(5):324-328. doi:10.1111/j.1600-0838.2004.00423.x.
Levai IK, Hull JH, Loosemore M, Greenwell J, Whyte G, Dickinson JW. Environmental influence on the prevalence and pattern of airway dysfunction in elite athletes: EIB in elite boxers and swimmers. Respirology. 2016;21(8):1391-1396. doi:10.1111/resp.12859.
Sandbakk Ø, Hegge AM, Losnegard T, Skattebo Ø, Tønnessen E, Holmberg H-C. The physiological capacity of the World’s highest ranked female cross-country skiers. Med Sci Sports Exerc. 2016;48(6):1091-1100. doi:10.1249/MSS.0000000000000862.
Heir T, Oseid S. Self-reported asthma and exercise-induced asthma symptoms in high-level competitive cross-country skiers. Scand J Med Sci Sports. 1994;4(2):128-133. doi:10.1111/j.1600-0838.1994.tb00415.x.
Sue-Chu M, Karjalainen EM, Laitinen A, Larsson L, Laitinen LA, Bjermer L. Placebo-controlled study of inhaled budesonide on indices of airway inflammation in bronchoalveolar lavage fluid and bronchial biopsies in cross-country skiers. Resp Int Rev Thoracic Dis. 2000;67(4):417-425. 10.1159/000029541.
Irewall T, Bäcklund C, Nordang L, Ryding M, Stenfors N. High prevalence of exercise-induced laryngeal obstruction in a cohort of elite cross-country skiers. Med Sci Sports Exerc. 2021;53(6):1134-1141. doi:10.1249/MSS.0000000000002581.
Aavikko A, Helenius I, Alaranta A, Vasankari T, Haahtela T. Asthma medication is increasingly prescribed for Finnish Olympic athletes-for a reason? J Asthma. 2012;49(7):744-749. doi:10.3109/02770903.2012.709293.
Kotaniemi J, Hassi J, Kataja M, et al. Does non-responder bias have a significant effect on the results in a postal questionnaire study? Eur J Epidemiol. 2001;17(9):809-817. doi:10.1023/A:1015615130459.
Kilpelainen M, Terho EO, Helenius H, Koskenvuo M. Validation of a new questionnaire on asthma, allergic rhinitis, and conjunctivitis in young adults. Allergy. 2001;56(5):377-384. doi:10.1034/j.1398-9995.2001.056005377.x.